Paragangliomas of the head and neck

Current Oncology Reports

Volumn 10, Issue 2, 2008, Pages 156-161

  Kupferman, Michael E ^a   Hanna, Ehab Y ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE B; SUCCINATE DEHYDROGENASE C; SUCCINATE DEHYDROGENASE D; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTERIOGRAPHY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; GENE MUTATION; GENETIC SCREENING; HEAD AND NECK TUMOR; HUMAN; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PATHOGENESIS; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE FRACTIONATION; REVIEW; STEREOTAXIC SURGERY; THREE DIMENSIONAL IMAGING; TOMOSCINTIGRAPHY;

GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; MEDICAL ONCOLOGY; MODELS, GENETIC; MUTATION; PARAGANGLIOMA; RADIOSURGERY; RADIOTHERAPY;

EID: 40849088026     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-008-0024-9     Document Type: Review

References (37)

1. Baysal BE, Ferrell RE, Willett-Brozick JE, et al.: Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000, 287:848-851.
2. Neumann HP, Bausch B, McWhinney SR, et al.: Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002, 346:1459-1466.
3. Astuti D, Latif F, Dallol A, et al.: Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001, 69:49-54.
4. Niemann S, Muller U: Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000, 26:268-270.
5. Jiménez C, Cote G, Arnold A, Gagel RF: Review: should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes? J Clin Endocrinol Metab 2006, 91:2851-2858.
6. Brandon M, Baldi P, Wallace DC: Mitochondrial mutations in cancer. Oncogene 2006, 25:4647-4662.
7. Bourgeron T, Rustin P, Chretien D, et al.: Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995, 11:144-149.
8. Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al.: Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab 2006, 91:827-836.
9. Heutink P, van der Mey AG, Sandkuijl LA, et al.: A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet 1992, 1:7-10.
10. Amar L, Bertherat J, Baudin E, et al.: Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005, 23:8812-8818.
11. Neumann HP, Pawlu C, Peczkowska M, et al.: Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004, 292:943-951.
12. Schiavi F, Boedeker C, Bausch B, et al.: Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 2005, 294:2057-2063.
13. Young WF, Jr, Abboud AL: Editorial: paraganglioma-all in the family. J Clin Endocrinol Metab 2006, 91:790-792.
14. Martin TP, Irving RM, Maher ER: The genetics of paragangliomas: a review. Clin Otolaryngol 2007, 32:7-11.
15. Ferner RE: Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 2007, 6:340-351.
16. Hu K, Persky MS: Multidisciplinary management of paragangliomas of the head and neck, Part 1. Oncology (Williston Park) 2003, 17:983-993.
17. van den Berg R: Imaging and management of head and neck paragangliomas. Eur Radiol 2005, 15:1310-1318.
18. Arnold SM, Strecker R, Scheffler K, et al.: Dynamic contrast enhancement of paragangliomas of the head and neck: evaluation with time-resolved 2D MR projection angiography. Eur Radiol 2003, 13:1608-1611.
19. van den Berg R, Verbist BM, Mertens BJ, et al.: Head and neck paragangliomas: improved tumor detection using contrast-enhanced 3D time-of-flight MR angiography as compared with fat-suppressed MR imaging techniques. AJNR Am J Neuroradiol 2004, 25:863-870.
20. Brink I, Hoegerle S, Klisch J, Bley TA: Imaging of pheochromocytoma and paraganglioma. Fam Cancer 2005, 4:61-68.
21. Hoegerle S, Ghanem N, Altehoefer C, et al.: 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging 2003, 30:689-694.
22. Pellitteri PK, Rinaldo A, Myssiorek D, et al.: Paragangliomas of the head and neck. Oral Oncol 2004, 40:563-575.
23. Rao AB, Koeller KK, Adair CF: From the archives of the AFIP: paragangliomas of the head and neck: radiologic-pathologic correlation. Radiographics 1999, 19:1605-1632.
24. Mafee MF, Raofi B, Kumar A, Muscato C: Glomus faciale, glomus jugulare, glomus tympanicum, glomus vagale, carotid body tumors, and simulating lesions. Role of MR imaging. Radiol Clin North Am 2000, 38:1059-1076.
25. Antonitsis P, Saratzis N, Velissaris I, et al.: Management of cervical paragangliomas: review of a 15-year experience. Langenbecks Arch Surg 2006, 391:396-402.
26. Timmers HJ, Kozupa A, Chen CC, et al.: Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol 2007, 25:2262-2269.
27. Duet M, Sauvaget E, Pételle B, et al.: Clinical impact of somatostatin receptor scintigraphy in the management of paragangliomas of the head and neck. J Nucl Med 2003, 44:1767-1774.
28. Bustillo A, Telischi F, Weed D, et al.: Octreotide scintigraphy in the head and neck. Laryngoscope 2004, 114:434-440.
29. Jackson CG: Glomus tympanicum and glomus jugulare tumors. Otolaryngol Clin North Am 2001, 34:941-970, vii.
30. Jackson CG: Neurologic skull base surgery for glomus tumors. Diagnosis for treatment planning and treatment options. Laryngoscope 1993, 103(Pt 2 Suppl 60):17-22.
31. Patel SJ, Sekhar LN, Cass SP, Hirsch BE: Combined approaches for resection of extensive glomus jugulare tumors. A review of 12 cases. J Neurosurg 1994, 80:1026-1038.
32. Boedeker CC, Ridder GJ, Schipper J: Paragangliomas of the head and neck: diagnosis and treatment. Fam Cancer 2005, 4:55-59.
33. Hu K, Persky MS: The multidisciplinary management of paragangliomas of the head and neck, Part 2. Oncology (Williston Park) 2003, 17:1143-1153; discussion 1154, 1158, 1161.
34. Pollock BE: Stereotactic radiosurgery in patients with glomus jugulare tumors. Neurosurg Focus 2004, 17:E10.
35. Gerosa M, Visca A, Rizzo P, et al.: Glomus jugulare tumors: the option of gamma knife radiosurgery. Neurosurgery 2006, 59:561-569.
36. Sheehan J, Kondziolka D, Flickinger J, Lunsford LD: Gamma knife surgery for glomus jugulare tumors: an intermediate report on efficacy and safety. J Neurosurg 2005, 102(Suppl):241-246.
37. Gottfried ON, Liu JK, Couldwell WT: Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus 2004, 17:E4.